357 filings
Page 11 of 18
6-K
TRIL
Trillium Therapeutics Inc.
18 Jun 18
Current report (foreign)
9:52am
6-K
TRIL
Trillium Therapeutics Inc.
15 Jun 18
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
14 Jun 18
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
7 Jun 18
Trillium Therapeutics Appoints Yaping Shou, MD, PHD As Chief Medical Officer
7:02am
6-K
TRIL
Trillium Therapeutics Inc.
5 Jun 18
Current report (foreign)
12:00am
EFFECT
TRIL
Trillium Therapeutics Inc.
1 Jun 18
Notice of effectiveness
12:15am
CORRESP
TRIL
Trillium Therapeutics Inc.
29 May 18
Correspondence with SEC
12:00am
UPLOAD
TRIL
Trillium Therapeutics Inc.
24 May 18
Letter from SEC
12:00am
F-3
TRIL
Trillium Therapeutics Inc.
16 May 18
Shelf registration (foreign)
5:16pm
6-K
TRIL
Trillium Therapeutics Inc.
11 May 18
Interim Condensed Consolidated Financial Statements
7:05am
6-K
TRIL
Trillium Therapeutics Inc.
18 Apr 18
Trillium Therapeutics Reports TTI-622 Preclinical Data at the 2018 Aacr Annual Meeting
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
12 Apr 18
Trillium Therapeutics to Report Preclinical Data on TTI-621 and TTI-622 at the Aacr Annual Meeting 2018
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
10 Apr 18
Current report (foreign)
12:00am
40-F/A
2017 FY
TRIL
Trillium Therapeutics Inc.
4 Apr 18
Annual report (Canada) (amended)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
20 Mar 18
Trillium Therapeutics’ TTI-621 Receives Orphan Drug Designation for the Treatment of Cutaneous T-cell Lymphoma
12:00am
40-F/A
2017 FY
TRIL
Trillium Therapeutics Inc.
13 Mar 18
Annual report (Canada) (amended)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
9 Mar 18
Trillium Therapeutics Reports Annual 2017 Financial and Operating Results
12:00am
40-F
2017 FY
TRIL
Trillium Therapeutics Inc.
9 Mar 18
Annual report (Canada)
12:00am
SC 13G
AWM Investment Company, Inc.
13 Feb 18
Trillium Therapeutics Inc.
12:00am
SC 13G/A
Baker Bros. Advisors LP
13 Feb 18
Trillium Therapeutics Inc.
12:00am